You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Using the publicly available ImmPort database, researchers standardized and analyzed immune-related data for more than 10,300 healthy individuals.
The company plans to develop tests for prostate cancer risk assessment, prostate cancer screening, and breast cancer screening.
An international research team studied how genetic factors control immune cell response to pathogens in healthy individuals.
Researchers hope to advance the technology to support an assay to help personalize oral cancer treatment by avoiding the development of mucositis.
The team showed the approach could successfully monitor cytokines in infants after heart surgery, and is involved now in a larger clinical study expanding this research.
This article has been updated from an earlier version with additional comments from Eliot Lurier.
By Turna Ray
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.